Skip to main content
OpenTrials

Clinical trial condition

Metastatic Cancer

Explore clinical trials studying Metastatic Cancer. Study availability and eligibility vary by location and protocol.

431 public trials 81 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Cancer trial results

Recruiting

SLV-154 Treatment of Advanced Cancers

NCT06771219

Conditions
Advanced Cancer, Advanced Solid Tumor, Metastatic Cancer, +5 more
Locations
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • Washington University St Louis, Missouri, United States
  • Astera Cancer Care East Brunswick, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Recruiting

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

NCT05267626

Conditions
Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +57 more
Locations
  • Sylvester Comprehensive Cancer Center - Miami Miami, Florida, United States
  • START Midwest Grand Rapids, Michigan, United States
  • Minnesota Oncology and Hematology PA Minneapolis, Minnesota, United States
  • Washington University St Louis, Missouri, United States
View all 17 locations
View Trial Details
Recruiting

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

NCT04585750

Conditions
Adnexal Diseases, Advanced Malignant Neoplasm, Advanced Solid Tumor, +81 more
Locations
  • University of California Irvine Chao Family Comprehensive Cancer Center Irvine, California, United States
  • University of San Diego Moores Cancer Center La Jolla, California, United States
  • UCLA Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 77 locations
View Trial Details
Recruiting

COntinue the SaMe Systemic Therapy After Local Ablative Therapy for Oligo Progression in Metastatic Breast Cancer - the COSMO Study

NCT05301881

Conditions
Breast Cancer Invasive, Metastatic Cancer, Neoplasm Metastasis, +5 more
Locations
  • Noordwest Ziekenhuisgroep Alkmaar, Netherlands
  • Antoni van Leeuwenhoek Amsterdam, Netherlands
  • Rijnstate Arnhem, Netherlands
  • Deventer ziekenhuis Deventer, Netherlands
View Trial Details
Recruiting

PRE-ISPY Phase I/II Oncology Platform Program

NCT05868226

Conditions
Adenocarcinoma, Adenocarcinoma of Colon, Breast Diseases, +51 more
Locations
  • The University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Birmingham, Alabama, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • The University of Chicago Medicine Comprehensive Cancer Center Chicago, Illinois, United States
  • UChicago Medicine Comprehensive Cancer Center at Silver Cross Hospital New Lenox, Illinois, United States
View Trial Details

Related conditions